LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 67 filers reported holding LOXO ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $7,664,000 | +614.3% | 54,719 | +770.5% | 0.01% | +700.0% |
Q3 2018 | $1,073,000 | -39.6% | 6,286 | -38.6% | 0.00% | -50.0% |
Q2 2018 | $1,776,000 | +1941.4% | 10,239 | +1258.0% | 0.00% | – |
Q1 2018 | $87,000 | +50.0% | 754 | +9.0% | 0.00% | – |
Q4 2017 | $58,000 | -70.7% | 692 | -67.7% | 0.00% | – |
Q3 2017 | $198,000 | -70.4% | 2,145 | -74.3% | 0.00% | -100.0% |
Q2 2017 | $670,000 | +33.7% | 8,349 | -29.8% | 0.00% | – |
Q1 2017 | $501,000 | +47.8% | 11,892 | +12.7% | 0.00% | – |
Q4 2016 | $339,000 | +1030.0% | 10,548 | +805.4% | 0.00% | – |
Q3 2016 | $30,000 | -9.1% | 1,165 | -17.6% | 0.00% | – |
Q2 2016 | $33,000 | -84.2% | 1,413 | -81.5% | 0.00% | – |
Q1 2016 | $209,000 | +154.9% | 7,640 | +165.7% | 0.00% | – |
Q4 2015 | $82,000 | – | 2,875 | +287400.0% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 1 | -99.5% | 0.00% | – |
Q2 2015 | $4,000 | +33.3% | 210 | +6.6% | 0.00% | – |
Q1 2015 | $3,000 | -57.1% | 197 | -68.2% | 0.00% | – |
Q4 2014 | $7,000 | +250.0% | 620 | +388.2% | 0.00% | – |
Q3 2014 | $2,000 | – | 127 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |